Abstract:Background: Cell surface carbohydrate antigens play a major role in the rejection of porcine xenografts. The most important for human recipients are α-1,3 Gal (Galactose-alpha-1,3-galactose) causing hyperacute rejection, also Neu5Gc (N-glycolylneuraminic acid) and Sd(a) blood group antigens both of which are likely to elicit acute vascular rejection given the known human immune status. Porcine cells with knockouts of the three genes responsible, GGTA1, CMAH and B4GALNT2, revealed minimal xenoreactive antibody binding after incubation with human serum. However, human leucocyte antigen (HLA) antibodies cross-reacted with swine leucocyte antigen class I (SLA-I). We previously demonstrated efficient generation of pigs with multiple xeno-transgenes placed at a single genomic locus. Here we wished to assess whether key xenoreactive antigen genes can be simultaneously inactivated and if combination with the multi-transgenic background further reduces antibody deposition and complement activation. Methods: Multiplex CRISPR/Cas9 gene editing and somatic cell nuclear transfer were used to generate pigs carrying functional knockouts of GGTA1, CMAH, B4GALNT2 and SLA class I. Fibroblasts derived from one- to four-fold knockout animals, and from multi-transgenic cells (human CD46, CD55, CD59, HO1 and A20) with the four-fold knockout were used to examine the effects on human IgG and IgM binding or complement activation in vitro. Results: Pigs were generated carrying four-fold knockouts of important xenoreactive genes. In vitro assays revealed that combination of all four gene knockouts reduced human IgG and IgM binding to porcine kidney cells more effectively than single or double knockouts. The multi-transgenic background combined with GGTA1 knockout alone reduced C3b/c and C4b/c complement activation to such an extent that further knockouts had no significant additional effect. Conclusion: We showed that pigs carrying several xenoprotective transgenes and knockouts of xenoreactive antigens can be readily generated and these modifications will have significant effects on xenograft survival.

Human-porcine MHC-I homology allows for antibody cross-reactivity

Anti-pig Antibodies in Swine Veterinarian Serum: Implications for Clinical Xenotransplantation

Anti‐pig antibodies in swine veterinarian serum: Implications for clinical xenotransplantation

Non‐Classical Swine Leukocyte Antigens SLA‐6, ‐7, and ‐8, Are Xenoantigens for Some Waitlisted Patients

[Xenogeneic Antigens and Immune Response in Pig to Man Xenograft].

Role of human and porcine MHC DRB1 alleles in determining the intensity of individual human anti-pig T-cell responses

Novel SLA class I alleles of Chinese pig strains and their significance in xenotransplantation

Examining epitope mutagenesis as a strategy to reduce and eliminate human antibody binding to class II swine leukocyte antigens

Patients on the Transplant Waiting List Have Anti-Swine Leukocyte Antigen Class I Antibodies

HLA Class I-sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes

Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins

Viable pigs after simultaneous inactivation of porcine MHC class I and three xenoreactive antigen genes GGTA1, CMAH and B4GALNT2

Eliminating Xenoantigen Expression on Swine RBC

Swine Leukocyte Antigen Class II Is a Xenoantigen

DIRECT AND INDIRECT RECOGNITION IN PIG-TO-MAN XENOTRANSPLANTATION

Characterization of swine leucocyte antigen alleles in a crossbred pig to be used in xenotransplant studies

Does human leukocyte antigens sensitization matter for xenotransplantation?

Co-expression of HLA-E and HLA-G on genetically modified porcine endothelial cells attenuates human NK cell-mediated degranulation

Modeling human anti-pig xenoimmune responses in a pig artery tissue grafted humanized mouse model

Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs

The desirable donor pig to eliminate all xenoreactive antigens